Clinical Characteristics of Pediatric Orbital Pseudotumors.
10.3341/jkos.2013.54.6.850
- Author:
Min Kyung KIM
1
;
Sun Young JANG
;
Jae Woo JANG
Author Information
1. Department of Ophthalmology, Kim's Eye Hospital, Myung-Gok Eye Research Institute, Konyang University College of Medicine, Seoul, Korea. jjw@kimeye.com
- Publication Type:Original Article
- Keywords:
Korea;
Orbital pseudotumor;
Pediatric pseudotumor;
Pseudotumor treatment;
Systemic steroid
- MeSH:
Adrenal Cortex Hormones;
Anti-Inflammatory Agents, Non-Steroidal;
Dacryocystitis;
Exophthalmos;
Eyelids;
Humans;
Inflammation;
Korea;
Myositis;
Orbit;
Orbital Pseudotumor;
Recurrence;
Retrospective Studies;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2013;54(6):850-856
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To describe the clinical manifestations, radiologic findings, and treatment outcomes of pediatric pseudotumors. METHODS: A retrospective chart review of patients diagnosed with pediatric pseudotumor (age under 20 years old) from August 2008 to February 2012 was performed. RESULTS: Thirteen patients (16 eyes) were included in this study. The mean age of the subjects was 14.2 years (5-20 years). Swollen eyelid (56.3%), ptosis (43.8%), conjunctival injection (18.8%), localized mass (18.8%), limitation of ocular movement (12.5%), proptosis (6.3%), and decreased visual acuity (6.3%) were found initially. Dacryoadenitis (62.5%), myositis (18.8%), anterior orbital inflammation (18.8%), and diffuse type (6.3%) were observed on orbital computed tomography (CT). Among the 13 patients (16 eyes), 8 patients (10 eyes) were administered oral systemic corticosteroids, 2 patients (2 eyes) received IV systemic corticosteroid, 1 patient (1 eye) received systemic corticosteroids combined with NSAID, and 2 patients (3 eyes) were prescribed NSAIDs only. Symptoms improved 4.1 days after initiation of treatment. CT scans revealed that one patient experienced diffuse-type disease recurrence twice. CONCLUSIONS: Orbital pseudotumors, which are rare in younger people, are likely to respond very well to corticosteroid treatment, and the recurrence of orbital inflammation is rare.
